A Double-Blind Clincal Study to Compare Single IV Doses of Palonesetron, .25 mg or .75 mg, and Dolasetron 100mg IV, in the Prevention of Moderately Emetogenic Chemotheraphy-Induced Nausea and Vomiting. Protocol No. PALO-99-04

  • Gallion, Holly (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/0010/1/01